BioWorld

Nov. 15, 2002

View Archived Issues

Untraditional Immune Complex Of CD137 Target, Agonistic Antibody Keep Lupus Murine Models Living

Read More

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Read More

Advisory Panel Unanimously Backs Roche's HCV Therapy

Read More

Scynexis, Roche Collaborate To Discover, Develop Drugs

Read More

Other News To Note

Read More

Celgene Buying Anthrogenesis For $45M, Expanding Portfolio

Celgene Corp. is shelling out $45 million in stock and options to acquire a subsidiary - a placental stem cell recovery company called Anthrogenesis Corp. (BioWorld Today) Read More

Neurocrine Reports Positive Data From First Phase III Insomnia Trial

Read More